ArticleFrontiers in pharmacology2022
Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 28 citations in OpenAlex.
- The Effect of COVID-19 Vaccines on Chronic Inflammatory Remodeling in NSTEMI Patients: A Galectin-3-Based Single-Center Study.Journal of clinical medicine · 2026Article
- Systematic Review: The Impact of COVID-19 Vaccination on Myocarditis Risk and Recovery.Clinics and practice · 2026Review
- Article
- Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example.American journal of epidemiology · 2025Article
- Core Concepts: Self-Controlled Designs in Pharmacoepidemiology.Pharmacoepidemiology and drug safety · 2025Review
- Impact of Comorbidities and Skin Diseases on Post-Vaccination Reactions: A Study on COVID-19 Vaccinations in Poland.Journal of clinical medicine · 2024Article
- Myocarditis associated with COVID-19 vaccination.NPJ vaccines · 2024Review
- Article
- The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.Drug safety · 2024Article
- Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine.JAMA network open · 2024Article
- The Validation Of COVID-19 Information In The Pharmacoepidemiological Research Database of Spain's Public Health System Data by Vaccination Status.Perspectives in health information managemen · 2024Article
- A severe case of rhabdomyolysis after Moderna mRNA anti-COVID-19 vaccine with a literature review.Clinical case reports · 2023Article
- Coronavirus disease 2019 vaccination in women and assisted reproductive technology.Fertility and sterility · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 9 institutions in 4 countries.
Sophie H BotsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Judit Riera-ArnauDepartment of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.
Svetlana V BelitserDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Davide MessinaAgenzia Regionale di Sanitá, Florence, Toscana, Italy.
Maria AragónFundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Ema AlsinaDepartment of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.
Ian J DouglasFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Carlos E DuránDepartment of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.
Patricia García-PozaSpanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Rosa GiniAgenzia Regionale di Sanitá, Florence, Toscana, Italy.
Ron M C HeringsPHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Consuelo HuertaSpanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Malede Mequanent SisayDepartment of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.
Mar Martín-PérezSpanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
Ivonne MartinDepartment of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.
Jetty A OverbeekPHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Olga PaolettiAgenzia Regionale di Sanitá, Florence, Toscana, Italy.
Meritxell Pallejà-MillánUnitat de Suport a la Recerca Tarragona-Reus, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Anna SchultzeFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Patrick SouvereinDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Karin M A SwartPHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Felipe VillalobosFundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Olaf H KlungelDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Miriam C J M SturkenboomDepartment of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.
Utrecht University · NLAgencia Española de Medicamentos y Productos Sanitarios · ESAgenzia Regionale di Sanità della Toscana · ITInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESPharmo Institute · NLVall d'Hebron Hospital Universitari · ESLondon School of Hygiene & Tropical Medicine · GBUniversitat Autònoma de Barcelona · ESUniversity Medical Center Utrecht · NL
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
adverse drug reactionCOVID-19 vaccinemyocarditispericarditispharmacovigilance
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.